11-cis-vaccenyl acetate: a volatile pheromone; a male-specific lipid that is transferred in the ejaculate to females during copulation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5363286 |
| CHEBI ID | 46274 |
| SCHEMBL ID | 1302527 |
| MeSH ID | M0508799 |
| Synonym |
|---|
| (z)-octadec-11-enyl acetate |
| 11-cis-vaccenyl acetate |
| (11z)-octadec-11-en-1-yl acetate |
| CHEBI:46274 |
| z-11-octadecen-1-ol acetate |
| [(z)-octadec-11-enyl] acetate |
| LMFA07010387 |
| 11z-octadecenyl acetate |
| SCHEMBL1302527 |
| 11-octadecen-1-ol, acetate, (11z)- |
| 6186-98-7 |
| vaccenyl acetate |
| cis-vaccenyl acetate |
| (11z)-11-octadecenyl acetate # |
| QSZKEDWVAOAFQY-HJWRWDBZSA-N |
| HMS3650F07 |
| acetyl (11z)-octadec-11-enoate |
| AKOS027288929 |
| HY-128900 |
| sr-01000946336 |
| SR-01000946336-1 |
| Q6584358 |
| 11-cis vaccenyl acetate |
| CS-0101985 |
| (z)-11-octadecenyl acetate |
| vaccenyl acetate, 11-cis- |
| 11-octadecen-1-ol, acetate, (z)- |
| unii-49m29zh9ts |
| 11-octadecen-1-ol, 1-acetate, (11z)- |
| 49m29zh9ts , |
| (z)-11-vaccenyl acetate |
| (z)-11-octadecen-1-ol acetate |
| DTXSID401028467 |
| (11z)-11-octadecen-1-yl acetate |
| PD019604 |
| Class | Description |
|---|---|
| acetate ester | Any carboxylic ester where the carboxylic acid component is acetic acid. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (32.56) | 29.6817 |
| 2010's | 27 (62.79) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.44) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 2 (4.65%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 41 (95.35%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||